Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Perkins

Showing results (21-30 of 247) with videos related to

Pageof 25
Sort By:
Diabetes Care|June 29, 2004
Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instrumentsLorne H Zinman, Vera Bril, Bruce A Perkins
Science (New York, N.Y.)|July 30, 2021
Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automationBruce A Perkins, Jennifer L Sherr, Chantal Mathieu
Canadian Journal of Diabetes|December 24, 2019
Talking Points for Helping Your Type 1 Diabetes Patient Decide About Hybrid Closed LoopBruce A Perkins, Nancy Cardinez, Christine F Opsteen
Diabetologia|December 11, 2024
Correction: Applying technologies to simplify strategies for exercise in type 1 diabetesBruce A Perkins, Lauren V Turner, Michael C Riddell
Canadian Journal of Diabetes|January 21, 2015
Uric acid as a biomarker and a therapeutic target in diabetesYuliya Lytvyn, Bruce A Perkins, David Z I Cherney
The New England Journal of Medicine|July 3, 2009
Diabetes complications and the renin-angiotensin systemBruce A Perkins, Lloyd Paul Aiello, Andrzej S Krolewski
Diabetes Technology & Therapeutics|November 21, 2025
Clinical Trials in Diabetes: Examining the Value of Use of Continuous Dual Glucose-Ketone MonitoringHalis Kaan Akturk, Bruce A Perkins, Timothy C Dunn
Diabetes Care|February 24, 2012
Heart rate variability and sensorimotor polyneuropathy in type 1 diabetesSteven Orlov, Vera Bril, Andrej Orszag, et al.
Canadian Journal of Diabetes|April 14, 2018
Neuropathy, Vera Bril, Ari Breiner, et al.
The New England Journal of Medicine|August 30, 2005
Cystatin C and the risk of deathBruce A Perkins, Robert G Nelson, Andrzej S Krolewski
Pageof 25

Showing results (21-30 of 247) with videos related to

Sort By:
Pageof 25
Diabetes Care|June 29, 2004
Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instrumentsLorne H Zinman, Vera Bril, Bruce A Perkins
Science (New York, N.Y.)|July 30, 2021
Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automationBruce A Perkins, Jennifer L Sherr, Chantal Mathieu
Canadian Journal of Diabetes|December 24, 2019
Talking Points for Helping Your Type 1 Diabetes Patient Decide About Hybrid Closed LoopBruce A Perkins, Nancy Cardinez, Christine F Opsteen
Diabetologia|December 11, 2024
Correction: Applying technologies to simplify strategies for exercise in type 1 diabetesBruce A Perkins, Lauren V Turner, Michael C Riddell
Canadian Journal of Diabetes|January 21, 2015
Uric acid as a biomarker and a therapeutic target in diabetesYuliya Lytvyn, Bruce A Perkins, David Z I Cherney
The New England Journal of Medicine|July 3, 2009
Diabetes complications and the renin-angiotensin systemBruce A Perkins, Lloyd Paul Aiello, Andrzej S Krolewski
Diabetes Technology & Therapeutics|November 21, 2025
Clinical Trials in Diabetes: Examining the Value of Use of Continuous Dual Glucose-Ketone MonitoringHalis Kaan Akturk, Bruce A Perkins, Timothy C Dunn
Diabetes Care|February 24, 2012
Heart rate variability and sensorimotor polyneuropathy in type 1 diabetesSteven Orlov, Vera Bril, Andrej Orszag, et al.
Canadian Journal of Diabetes|April 14, 2018
Neuropathy, Vera Bril, Ari Breiner, et al.
The New England Journal of Medicine|August 30, 2005
Cystatin C and the risk of deathBruce A Perkins, Robert G Nelson, Andrzej S Krolewski
Pageof 25